JP2010540636A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010540636A5 JP2010540636A5 JP2010527993A JP2010527993A JP2010540636A5 JP 2010540636 A5 JP2010540636 A5 JP 2010540636A5 JP 2010527993 A JP2010527993 A JP 2010527993A JP 2010527993 A JP2010527993 A JP 2010527993A JP 2010540636 A5 JP2010540636 A5 JP 2010540636A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- animal
- cognitive function
- amount effective
- enhance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241001465754 Metazoa Species 0.000 claims 12
- 230000003920 cognitive function Effects 0.000 claims 10
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims 8
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 claims 8
- 229940057917 medium chain triglycerides Drugs 0.000 claims 8
- 239000003963 antioxidant agent Substances 0.000 claims 4
- 235000019156 vitamin B Nutrition 0.000 claims 4
- 239000011720 vitamin B Substances 0.000 claims 4
- 229930003270 Vitamin B Natural products 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- 230000002708 enhancing effect Effects 0.000 claims 3
- 230000032683 aging Effects 0.000 claims 2
- 230000003078 antioxidant effect Effects 0.000 claims 2
- 235000013305 food Nutrition 0.000 claims 2
- 208000000044 Amnesia Diseases 0.000 claims 1
- 239000004475 Arginine Substances 0.000 claims 1
- 208000028698 Cognitive impairment Diseases 0.000 claims 1
- 208000022540 Consciousness disease Diseases 0.000 claims 1
- 206010012289 Dementia Diseases 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims 1
- 230000000386 athletic effect Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 208000010877 cognitive disease Diseases 0.000 claims 1
- 230000001149 cognitive effect Effects 0.000 claims 1
- 230000007423 decrease Effects 0.000 claims 1
- 235000014113 dietary fatty acids Nutrition 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- 229930195729 fatty acid Natural products 0.000 claims 1
- 239000000194 fatty acid Substances 0.000 claims 1
- 150000004665 fatty acids Chemical class 0.000 claims 1
- 235000021323 fish oil Nutrition 0.000 claims 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99766507P | 2007-10-04 | 2007-10-04 | |
| US60/997,665 | 2007-10-04 | ||
| PCT/US2008/011424 WO2009045481A1 (en) | 2007-10-04 | 2008-10-02 | Compositions and methods for enhancing cognitive function |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010540636A JP2010540636A (ja) | 2010-12-24 |
| JP2010540636A5 true JP2010540636A5 (enExample) | 2011-11-17 |
| JP5931337B2 JP5931337B2 (ja) | 2016-06-08 |
Family
ID=40526561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010527993A Active JP5931337B2 (ja) | 2007-10-04 | 2008-10-02 | 認知機能を高める組成物及び方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20100292330A1 (enExample) |
| EP (1) | EP2194781B2 (enExample) |
| JP (1) | JP5931337B2 (enExample) |
| CN (1) | CN101820754A (enExample) |
| AU (3) | AU2008307494B2 (enExample) |
| BR (1) | BRPI0818301B1 (enExample) |
| CA (1) | CA2701179C (enExample) |
| ES (1) | ES2664777T5 (enExample) |
| HU (1) | HUE037628T2 (enExample) |
| MX (1) | MX2010003568A (enExample) |
| NO (1) | NO2194781T3 (enExample) |
| PL (1) | PL2194781T5 (enExample) |
| RU (1) | RU2507742C2 (enExample) |
| TR (1) | TR201807131T4 (enExample) |
| WO (1) | WO2009045481A1 (enExample) |
| ZA (1) | ZA201003084B (enExample) |
Families Citing this family (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004245567B2 (en) | 2003-06-03 | 2011-06-23 | Oxford University Innovation Limited | Nutritional supplements and therapeutic compositions comprising (R)-3-hydroxybutyrate derivatives |
| AU2008347177B2 (en) | 2008-01-04 | 2014-04-17 | Société des Produits Nestlé S.A. | Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions |
| WO2010138869A1 (en) | 2009-05-29 | 2010-12-02 | The Trustees Of Columbia University In The City Of New York | Modulation of phospholipase d for the treatment of neurodegenerative disorders |
| BR112012005540A2 (pt) | 2009-09-11 | 2016-04-26 | Nestec Sa | composições e métodos para melhora da função cognitiva e funções relacionadas em animais |
| GB201002983D0 (en) * | 2010-02-22 | 2010-04-07 | Tdeltas Ltd | Nutritinal composition |
| WO2012044242A1 (en) | 2010-09-29 | 2012-04-05 | Procordia Food Ab | Use of a food product comprising viscous fibres which has a beneficial effect on cognitive performance. |
| BR112013018839A2 (pt) * | 2011-01-25 | 2016-09-27 | Nestec Sa | métodos e composições para o tratamento, a redução ou a prevenção de deterioração do sistema visual dos animais |
| WO2012125020A1 (en) | 2011-03-14 | 2012-09-20 | N.V. Nutricia | Method for treating neurotrauma |
| CN103547258B (zh) | 2011-03-17 | 2017-10-20 | 特兰斯德梅尔生物工艺股份有限公司 | 局部一氧化氮系统及其使用方法 |
| AU2012231351B2 (en) * | 2011-03-18 | 2016-03-10 | Société des Produits Nestlé S.A. | Compositions and methods useful for ameliorating age related maladies |
| US20140134135A1 (en) * | 2011-05-10 | 2014-05-15 | Nestec Sa | Methods and compositions for preserving lean body mass during weight loss |
| CA2835429A1 (en) * | 2011-05-10 | 2012-11-15 | Nestec S.A. | Methods and compositions for promoting lean body mass growth |
| US8183227B1 (en) | 2011-07-07 | 2012-05-22 | Chemo S. A. France | Compositions, kits and methods for nutrition supplementation |
| US8168611B1 (en) | 2011-09-29 | 2012-05-01 | Chemo S.A. France | Compositions, kits and methods for nutrition supplementation |
| US8551532B2 (en) | 2011-11-02 | 2013-10-08 | Kuwait University | Method of making an anti-inflammatory composition |
| US8871258B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Treatment and prevention of learning and memory disorders |
| US8871262B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Compositions and methods for treatment of osteoporosis and other indications |
| US8871261B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Cancer treatments and compositions for use thereof |
| US8871256B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Methods and systems for treatment of inflammatory diseases with nitric oxide |
| US8871259B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Techniques and systems for treatment of neuropathic pain and other indications |
| US8871257B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery |
| US8871260B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Methods and compositions for muscular and neuromuscular diseases |
| US8871255B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Treatment of skin and soft tissue infection with nitric oxide |
| US8871254B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system |
| US9265458B2 (en) | 2012-12-04 | 2016-02-23 | Sync-Think, Inc. | Application of smooth pursuit cognitive testing paradigms to clinical drug development |
| US9380976B2 (en) | 2013-03-11 | 2016-07-05 | Sync-Think, Inc. | Optical neuroinformatics |
| GB201304467D0 (en) | 2013-03-12 | 2013-04-24 | Tdeltas Ltd | Compound for use in protecting skin |
| US9393265B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
| US20140271937A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
| US9314422B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
| US20140271731A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
| US9393264B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
| US9724419B2 (en) | 2013-03-13 | 2017-08-08 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
| US9320758B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
| US9314417B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
| US9314423B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Hair treatment systems and methods using peptides and other compositions |
| US20140271938A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
| US9241899B2 (en) | 2013-03-13 | 2016-01-26 | Transdermal Biotechnology, Inc. | Topical systems and methods for treating sexual dysfunction |
| US9339457B2 (en) | 2013-03-13 | 2016-05-17 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
| US9295636B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
| US9320706B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
| US9295637B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Compositions and methods for affecting mood states |
| US9387159B2 (en) | 2013-03-13 | 2016-07-12 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
| US9849160B2 (en) | 2013-03-13 | 2017-12-26 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
| US9687520B2 (en) | 2013-03-13 | 2017-06-27 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
| US9314433B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
| US9295647B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
| US9750787B2 (en) | 2013-03-13 | 2017-09-05 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
| KR101588247B1 (ko) * | 2013-04-17 | 2016-01-25 | 경희대학교 산학협력단 | 뇌졸중 또는 퇴행성 뇌질환 예방 또는 치료용 조성물 |
| WO2015042137A1 (en) * | 2013-09-23 | 2015-03-26 | Almendra Americas, LLC | Sweetener composition, sweetener products, and methods of sweetening |
| CN103609752B (zh) * | 2013-12-02 | 2016-05-25 | 内蒙古伊利实业集团股份有限公司 | 一种改善脑部认知功能的组合物及其制备方法与应用 |
| US20160101081A1 (en) * | 2014-10-10 | 2016-04-14 | Nestec Sa | Compositions and methods for enhancing mobility or activity or treating frailty |
| US9959628B2 (en) * | 2014-11-21 | 2018-05-01 | Christopher M. MUTTI | Imaging system for object recognition and assessment |
| US10668041B2 (en) | 2014-12-08 | 2020-06-02 | Societe Des Produits Nestle Sa | Compositions and methods comprising medium chain triglycerides for treatment of epilepsy |
| LT3229790T (lt) * | 2014-12-08 | 2019-12-10 | Nestle Sa | Kompozicijos, apimančios vidutinės grandinės trigliceridus, skirtos panaudoti epilepsijos gydyme |
| CA2987033C (en) * | 2015-06-22 | 2023-11-28 | Nestec S.A. | Compositions and methods for enhancing neurogenesis in animals |
| AU2016363511A1 (en) * | 2015-12-04 | 2018-05-10 | Société des Produits Nestlé S.A. | Method for improving cognition |
| CN105663109A (zh) * | 2015-12-29 | 2016-06-15 | 浙江旭晨医药科技有限公司 | 甘油三酯类化合物在制备治疗神经退行性疾病药物中的应用 |
| GB2547903A (en) * | 2016-03-01 | 2017-09-06 | Dodson & Horrell Ltd | Antioxidant mix for learning |
| CN109689041A (zh) * | 2016-09-29 | 2019-04-26 | 雀巢产品技术援助有限公司 | 作为未患痴呆患者的神经保护剂的ω-3脂肪酸和胆碱 |
| MX2019010484A (es) * | 2017-04-11 | 2019-10-17 | Nestle Sa | Niveles de acidos grasos omega-3 y vitamina d para identificar y atenuar el envejecimiento congnitivo en individuos. |
| JP7030194B2 (ja) | 2017-11-17 | 2022-03-04 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | オメガ－３ポリ不飽和および中鎖脂肪酸を含む組成物 |
| EP3801064B1 (en) * | 2018-06-07 | 2024-10-09 | Société des Produits Nestlé S.A. | Methods and compositions for increasing ketone bodies in animals |
| EP3806840A4 (en) * | 2018-06-15 | 2022-04-13 | Youhealth Biotech, Limited | COMPOSITION AND METHODS OF MODULATING ELOVL2 |
| JP7270160B2 (ja) * | 2018-08-07 | 2023-05-10 | 国立大学法人 香川大学 | 乳化イサダオイル |
| US12458617B2 (en) | 2019-05-24 | 2025-11-04 | Hill's Pet Nutrition, Inc. | Pet food compositions comprising caprylic acid and docosahexaenoic acid and/or eicosapetaenoic acid for use in treating struvite urolithiasis |
| CN114828648A (zh) * | 2019-12-19 | 2022-07-29 | 希尔氏宠物营养品公司 | 宠物食物组合物 |
| CN112662800B (zh) * | 2020-12-28 | 2022-12-20 | 广西大学 | 水稻耐冷主效qtl cts12的分子标记引物及其标记方法和应用 |
| CN119344377B (zh) * | 2024-12-27 | 2025-03-25 | 内蒙古伊利实业集团股份有限公司 | 一种有助于提升和/或改善个体社会行为的营养组合物及其应用 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2018A (en) * | 1841-03-26 | Joseph francis | ||
| US5780039A (en) * | 1992-04-23 | 1998-07-14 | Novartis Nutrition Ag | Orally-ingestible nutrition compositions having improved palatability |
| US5714472A (en) * | 1993-12-23 | 1998-02-03 | Nestec Ltd. | Enternal formulation designed for optimized nutrient absorption and wound healing |
| US5723446A (en) * | 1993-12-23 | 1998-03-03 | Nestec Ltd. | Enteral formulation designed for optimized nutrient absorption and wound healing |
| US5728678A (en) * | 1995-06-06 | 1998-03-17 | Nestec Ltd. | Method and composition for providing nutrition to a renal failure patient |
| US5977138A (en) * | 1996-08-15 | 1999-11-02 | Schering Corporation | Ether muscarinic antagonists |
| DE19757414A1 (de) * | 1997-12-23 | 1999-07-01 | Nutricia Nv | Fettmischung |
| IL147112A0 (en) * | 1999-06-14 | 2002-08-14 | Ford Henry Health System | Nitric oxide donors for inducing neurogenesis |
| US7655423B2 (en) | 1999-06-14 | 2010-02-02 | Henry Ford Health System | Nitric oxide donors for inducing neurogenesis |
| US6835750B1 (en) * | 2000-05-01 | 2004-12-28 | Accera, Inc. | Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II |
| US20070179197A1 (en) * | 2000-05-01 | 2007-08-02 | Accera, Inc. | Compositions and methods for improving or preserving brain function |
| US20080009467A1 (en) * | 2000-05-01 | 2008-01-10 | Accera, Inc. | Combinations of medium chain triglycerides and therapeutic agents for the treatment and prevention of alzheimers disease and other diseases resulting from reduced neuronal metabolism |
| US20050002992A1 (en) * | 2003-06-17 | 2005-01-06 | Mccleary Edward Larry | Foods, beverages, condiments, spices and salad dressings with specialized supplements |
| US6964969B2 (en) * | 2001-04-19 | 2005-11-15 | Mccleary Edward Larry | Composition and method for treating impaired or deteriorating neurological function |
| AU2002336638A1 (en) * | 2001-10-12 | 2003-04-28 | Cornell Research Foundation, Inc. | Reversing or preventing premature vascular senescence |
| NL1019368C2 (nl) * | 2001-11-14 | 2003-05-20 | Nutricia Nv | Preparaat voor het verbeteren van receptorwerking. |
| US20030113701A1 (en) * | 2001-12-13 | 2003-06-19 | William Gartner | Self-scoring method and apparatus for early self-screening of neurological disease |
| US20040087490A1 (en) * | 2002-09-20 | 2004-05-06 | Troup John P. | Nutritional compositions |
| WO2005023021A1 (ja) * | 2003-09-02 | 2005-03-17 | Bbk Bio Corporation | ダイエット食品 |
| US8715717B2 (en) * | 2003-09-05 | 2014-05-06 | Hill's Pet Nutrition, Inc. | Composition for animal consumption |
| WO2005063050A1 (en) * | 2003-12-19 | 2005-07-14 | Abbott Laboratories | Method of increasing lean body mass and reducing body fat mass in infants |
| US20060002985A1 (en) * | 2004-07-02 | 2006-01-05 | Zicker Steven C | Compositions and methods for decreasing age-related deterioration in mental activities in companion animals |
| US8324276B2 (en) * | 2005-01-24 | 2012-12-04 | Pronova Biopharma Norge As | Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction |
| CN1810257A (zh) * | 2005-05-26 | 2006-08-02 | 钟健琳 | 活脑素口服液 |
| JP5371429B2 (ja) * | 2005-08-26 | 2013-12-18 | ネステク ソシエテ アノニム | 機能的な血管の完全性及び細胞生存を改善し、脳の虚血における又は虚血エピソード後のアポトーシスを減少するための組成物及び方法 |
| BRPI0617175A2 (pt) * | 2005-09-30 | 2011-07-12 | Nestec Sa | composições, bem como uso de ácidos graxos poli-insaturados de cadeia longa (lcpufa) na preparação das mesmas, para melhora da função cognitiva |
| BRPI0619905A2 (pt) | 2005-12-15 | 2011-10-25 | Nestec Sa | composições e métodos para conservar função cerebral |
| PL1800675T4 (pl) * | 2005-12-23 | 2012-02-29 | Nutricia Nv | Kompozycja zawierająca wielonienasycone kwasy tłuszczowe, białka, mangan, i/lub molibden oraz nukleozydy/nukleotydy do leczenia otępienia |
| WO2009002145A1 (en) † | 2007-06-26 | 2008-12-31 | N.V. Nutricia | Lipid composition for improving function of brain functioning |
| AU2008347177B2 (en) * | 2008-01-04 | 2014-04-17 | Société des Produits Nestlé S.A. | Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions |
-
2008
- 2008-10-02 CA CA2701179A patent/CA2701179C/en active Active
- 2008-10-02 EP EP08835957.5A patent/EP2194781B2/en active Active
- 2008-10-02 JP JP2010527993A patent/JP5931337B2/ja active Active
- 2008-10-02 AU AU2008307494A patent/AU2008307494B2/en active Active
- 2008-10-02 US US12/734,014 patent/US20100292330A1/en not_active Abandoned
- 2008-10-02 TR TR2018/07131T patent/TR201807131T4/tr unknown
- 2008-10-02 CN CN200880110329A patent/CN101820754A/zh active Pending
- 2008-10-02 HU HUE08835957A patent/HUE037628T2/hu unknown
- 2008-10-02 ES ES08835957T patent/ES2664777T5/es active Active
- 2008-10-02 BR BRPI0818301-5A patent/BRPI0818301B1/pt active IP Right Grant
- 2008-10-02 WO PCT/US2008/011424 patent/WO2009045481A1/en not_active Ceased
- 2008-10-02 PL PL08835957T patent/PL2194781T5/pl unknown
- 2008-10-02 RU RU2010117221/15A patent/RU2507742C2/ru active
- 2008-10-02 NO NO08835957A patent/NO2194781T3/no unknown
- 2008-10-02 MX MX2010003568A patent/MX2010003568A/es active IP Right Grant
-
2010
- 2010-05-03 ZA ZA2010/03084A patent/ZA201003084B/en unknown
-
2013
- 2013-05-17 AU AU2013205916A patent/AU2013205916B2/en active Active
-
2016
- 2016-04-27 AU AU2016202685A patent/AU2016202685B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jin et al. | Regulation of growth, tissue fatty acid composition, biochemical parameters and lipid related genes expression by different dietary lipid sources in juvenile black seabream, Acanthopagrus schlegelii | |
| Gladyshev et al. | Production of EPA and DHA in aquatic ecosystems and their transfer to the land | |
| Teoh et al. | Erratum to “Genetically improved farmed Nile tilapia and red hybrid tilapia showed differences in fatty acid metabolism when fed diets with added fish oil or a vegetable oil blend” | |
| RU2013146517A (ru) | Композиции и способы, пригодные для облегчения возрастных заболеваний | |
| Kumar et al. | Omega-3 fatty acids effectively modulate growth performance, immune response, and disease resistance in fish against multiple stresses | |
| Austreng et al. | Digestibility of fat and fatty acids in rainbow trout and mink | |
| Saito et al. | High levels of n− 3 polyunsaturated fatty acids in Euphausia pacifica and its role as a source of docosahexaenoic and icosapentaenoic acids for higher trophic levels | |
| WO2008147562A3 (en) | Dietary formulations and methods for treatment of inflammation and other disorders | |
| RU2747879C2 (ru) | Композиции из рафинированного масла и способы их изготовления | |
| JP2014510530A5 (ja) | アルギニンレベルを増加させる栄養組成物 | |
| JP2014515011A5 (enExample) | ||
| JP2006501840A5 (enExample) | ||
| CA2660291A1 (en) | Methods of improving bone health and muscle health | |
| JP2015143248A5 (enExample) | ||
| JP2014505702A5 (enExample) | ||
| JP2020503036A5 (enExample) | ||
| Dasilva et al. | A lipidomic study on the regulation of inflammation and oxidative stress targeted by marine ω-3 PUFA and polyphenols in high-fat high-sucrose diets | |
| NZ630210A (en) | Nutritional compositions including rrr -alpha tocopherol and polyunsaturated fatty acids | |
| JP2014514248A5 (enExample) | ||
| ATE547005T1 (de) | Nährende speiseölzusammensetzungen und verfahren zu ihrer herstellung | |
| JP2014532773A5 (enExample) | ||
| WO2015171960A1 (en) | Methods and compositions comprising 10-hydroxy-2-decenoic acid | |
| ES2376225T5 (es) | Genes de elongasa y usos de los mismos | |
| CN105166415A (zh) | 一种改善猪生长和肠道健康的不同链长脂肪组合物及其应用 | |
| BR112014014130A2 (pt) | tratamento ou redução de condições dentárias com ésteres de ascorbilo |